Hepatocyte growth factor secreted by cultured adipocytes promotes tube formation of vascular endothelial cells in vitro

International Journal of Obesity

Volumn 30, Issue 11, 2006, Pages 1676-1684

  Saiki, A ^a   Watanabe, F ^a   Murano, T ^a   Miyashita, Y ^a   Shirai, K ^a  

^a TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

Author keywords

Adipocyte; Angiogenesis; Hepatocyte growth factor; Pioglitazone; RNA interference

Indexed keywords

MESSENGER RNA; PIOGLITAZONE; SCATTER FACTOR; SMALL INTERFERING RNA; VASCULOTROPIN;

ADIPOCYTE; ADULT; AGED; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; VASCULAR ENDOTHELIUM;

3T3 CELLS; ADIPOCYTES; ANIMALS; CELLS, CULTURED; CULTURE MEDIA; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL CELLS; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MICE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; RNA, MESSENGER; RNA, SMALL INTERFERING; THIAZOLIDINEDIONES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33750479396     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803316     Document Type: Article

References (34)

1. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Cancer Res 1986; 46: 467-473.
2. Hausman GJ, Richardson LR. Histochemical and ultrastructural analysis of developing adipocytes in the fetal pig. Acta Anat 1982; 114: 228-247.
3. Crandall DL, Hausman GJ, Kral JG. A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 1997; 4: 211-232.
4. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001; 60: 349-356.
5. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretary organ. Proc Nutr Soc 2001; 60: 329-339.
6. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
7. Yamauchi T, Kamon J,Waki H, Murakami K, Motojima K, Komeda K et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPAR gamma) deficiency and PPAR gamma agonist improve insulin resistance. J Biol Chem 2001; 276: 41245-41254.
8. Skurk T, Hauner H. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1. Int Obes Relat Metab Disord 2004; 28: 1357-1364.
9. Caro J, Sinha M, Kolaczynski J, Zhang P, Considine R. Leptin: the tale of an obesity gene. Diabetes 1996; 45: 1445-1462.
10. Sharma A, Janke J, Gorzeliniak K, Engeli S, Luft C. Angiotensin blockade prevents type 2 diabetes by formation of fat cells. Hypertension 2002; 40: 609-622.
11. Gorzeliniak K, Engeli S, Janke J, Luft C, Sharma A. Hormonal regulation of the human adipose-tissue rennin-angiotensin system: relationship to obesity and hypertension. J Hypertens 2002; 20: 965-973.
12. Mick GJ, Wang X, McCormick K. White adipocyte vascular endothelial growth factor: regulation by insulin. Endocrinology 2002; 143: 948-953.
13. Nakagami H, Morishita R, Yamamoto K, Taniyama Y, Aoki M, Matsumoto K et al. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells. Hypertension 2001; 37: 581-586.
14. Morishita R, Sakaki M, Yamamoto K, Iguchi S, Aoki M, Yamasaki K et al. Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene. Circulation 2002; 105: 1491-1496.
15. Hockel M, Schlenger K, Doctrow S, Kissel T, Vaupel P. Therapeutic angiogenesis. Arch Surg 1993; 128: 423-429.
16. Funatsu T, Sawa Y, Ohtake S, Takahashi T, Matsumiya G, Matsuura N et al. Therapeutic angiogenesis in the ischemic canine heart induced by myocardial injection of naked complementary DNA plasmid encoding hepatocyte growth factor. J Thorac Cardiovasc Surg 2002; 124: 1099-1105.
17. Shiota G, Umeki K, Okano J, Kawasaki H. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases. J Med 1995; 26: 295-308.
18. Rehman J, Considine R, Bovenkerk J, Li J, Slavens C, Jones R et al. Obesity is associated with increased levels of circulating hepatocyte growth factor. J Am Coll Cardiol 2003; 41: 1408-1413.
19. Elbashir SM, Lendeckel W, Tuschi T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001; 15: 188-200.
20. Claffey KP, Wilkison WO, Spiegelman BM. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J Biol Chem 1992; 267: 16317-16322.
21. Silha JV, Krsek M, Sucharda P, Murphy LJ. Angiogenic factors are elevated in overweight and obese individuals. Int J Obes Relat Metab Disord 2005; 29: 1308-1314.
22. Bouloumie A, Sengines C, Portalan G, Galitzky J, Lafontan M. Adipocyte produces matrix metalloproteinases 2 and 9 involvement in adipose differentiation. Diabetes 2001; 50: 2080-2086.
23. Chavey C, Mari B, Mounthouel M, Bonnafous S, Anglard P, Obberghen E et al. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 2003; 278: 11888-11896.
24. Dobson D, Kambe A, Block E, Dion T, Lu H, Castellot J et al. 1-Butyryl-glycerol: a novel angiogenesis factor secreted by differentiating adipocytes. Cell 1990; 61: 223-230.
25. Bouloumie A, Drexler H, Lafontan M, Busse R. Leptin, the product of gene, promotes angiogenesis. Circ Res 1998; 83: 1059-1066.
26. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994; 79: 1147-1156.
27. Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci USA 1986; 83: 6489-6493.
28. Morishita R, Nakamura S, Hayashi S, Taniyama Y, Moriguchi A, Nagano T et al. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 1999; 33: 1379-1384.
29. Aoki M, Morishita R, Taniyama Y, Kaneda Y, Ogihara T. Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic disease. J Atheroscler Thomb 2000; 7: 71-76.
30. Taniyama Y, Morishita R, Hiraoka K, Aoki M, Nakagami H, Yamasaki K et al. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes. Circulation 2001; 104: 2344-2350.
31. Yasuda S, Noguchi T, Gohda M, Arai T, Tsutsui N, Matsuda T et al. Single low-dose administration of human recombinant hepatocyte growth factor attenuates intimal hyperplasia in a balloon-injured rabbit iliac artery model. Circulation 2000; 101: 2546-2549.
32. Seidel C, Borset M, Turesson I, Abildgaard N, Sundan A, Waage A. Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group. Blood 1998; 91: 806-812.
33. Nishimura M, Nakano K, Ushiyama M, Nanbu A, Ohtsuka K, Takahashi H et al. Increased serum concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy. J Clin Endocrinol Metab 1998; 83: 195-198.
34. Tateishi J, Waku S, Masutani M, Ohyanagi M, Iwasaki T. Hepatocyte growth factor as a potential predictor of the presence of atherosclerotic aorto-iliac artery disease. Am Heart J 2002; 143: 272-276.